Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 16 studies | 62% ± 22% | |
microglial cell | 14 studies | 42% ± 19% | |
glutamatergic neuron | 11 studies | 73% ± 20% | |
GABAergic neuron | 10 studies | 42% ± 21% | |
neuron | 9 studies | 42% ± 15% | |
endothelial cell | 9 studies | 31% ± 16% | |
oligodendrocyte | 9 studies | 29% ± 12% | |
fibroblast | 7 studies | 22% ± 4% | |
pericyte | 7 studies | 23% ± 7% | |
retinal bipolar neuron | 5 studies | 54% ± 23% | |
endothelial cell of lymphatic vessel | 5 studies | 24% ± 11% | |
smooth muscle cell | 5 studies | 17% ± 2% | |
interneuron | 5 studies | 41% ± 19% | |
epithelial cell | 4 studies | 27% ± 13% | |
GABAergic interneuron | 3 studies | 33% ± 1% | |
granule cell | 3 studies | 21% ± 3% | |
macrophage | 3 studies | 25% ± 4% | |
OFF-bipolar cell | 3 studies | 49% ± 6% | |
ON-bipolar cell | 3 studies | 67% ± 12% | |
rod bipolar cell | 3 studies | 72% ± 13% | |
Schwann cell | 3 studies | 46% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 40% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2082.47 | 2635 / 2642 | 100% | 36.71 | 702 / 705 |
kidney | 100% | 949.40 | 89 / 89 | 88% | 7.46 | 791 / 901 |
adrenal gland | 91% | 494.47 | 235 / 258 | 84% | 21.13 | 194 / 230 |
skin | 82% | 548.82 | 1488 / 1809 | 86% | 17.59 | 407 / 472 |
ovary | 91% | 455.37 | 164 / 180 | 75% | 6.96 | 324 / 430 |
prostate | 95% | 730.34 | 233 / 245 | 71% | 9.01 | 356 / 502 |
breast | 100% | 1088.24 | 459 / 459 | 61% | 5.14 | 687 / 1118 |
intestine | 92% | 827.89 | 889 / 966 | 63% | 4.76 | 333 / 527 |
lung | 98% | 825.64 | 565 / 578 | 50% | 3.91 | 577 / 1155 |
thymus | 94% | 534.25 | 614 / 653 | 49% | 4.05 | 295 / 605 |
stomach | 82% | 468.52 | 293 / 359 | 59% | 4.82 | 170 / 286 |
bladder | 100% | 961.57 | 21 / 21 | 38% | 3.19 | 191 / 504 |
liver | 78% | 456.81 | 177 / 226 | 59% | 4.00 | 240 / 406 |
uterus | 90% | 505.04 | 153 / 170 | 37% | 4.25 | 168 / 459 |
pancreas | 50% | 190.27 | 165 / 328 | 67% | 3.75 | 120 / 178 |
esophagus | 79% | 788.75 | 1143 / 1445 | 26% | 1.60 | 48 / 183 |
blood vessel | 100% | 1591.90 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1772.78 | 803 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 1266.82 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 87% | 549.51 | 752 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 41% | 2.76 | 33 / 80 |
tonsil | 0% | 0 | 0 / 0 | 40% | 3.23 | 18 / 45 |
spleen | 11% | 38.03 | 26 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.32 | 1 / 29 |
peripheral blood | 0% | 1.30 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006397 | Biological process | mRNA processing |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0017124 | Molecular function | SH3 domain binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0005515 | Molecular function | protein binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | KHDRBS3 |
Protein name | KH RNA binding domain containing, signal transduction associated 3 Alternative protein KHDRBS3 KH domain-containing, RNA-binding, signal transduction-associated protein 3 (RNA-binding protein T-Star) (Sam68-like mammalian protein 2) (SLM-2) (Sam68-like phosphotyrosine protein) |
Synonyms | SALP SLM2 |
Description | FUNCTION: RNA-binding protein that plays a role in the regulation of alternative splicing and influences mRNA splice site selection and exon inclusion. Binds preferentially to the 5'-[AU]UAAA-3' motif in vitro. Binds optimally to RNA containing 5'-[AU]UAA-3' as a bipartite motif spaced by more than 15 nucleotides. Binds poly(A). RNA-binding abilities are down-regulated by tyrosine kinase PTK6 . Involved in splice site selection of vascular endothelial growth factor . In vitro regulates CD44 alternative splicing by direct binding to purine-rich exonic enhancer (By similarity). Can regulate alternative splicing of neurexins NRXN1-3 in the laminin G-like domain 6 containing the evolutionary conserved neurexin alternative spliced segment 4 (AS4) involved in neurexin selective targeting to postsynaptic partners such as neuroligins and LRRTM family members . Targeted, cell-type specific splicing regulation of NRXN1 at AS4 is involved in neuronal glutamatergic synapse function and plasticity (By similarity). May regulate expression of KHDRBS2/SLIM-1 in defined brain neuron populations by modifying its alternative splicing (By similarity). Can bind FABP9 mRNA (By similarity). May play a role as a negative regulator of cell growth. Inhibits cell proliferation. .; FUNCTION: (Microbial infection) Involved in post-transcriptional regulation of HIV-1 gene expression. . |
Accessions | ENST00000522578.2 E5RJZ9 A0A994J7I5 H0YAQ1 L8EC47 ENST00000517394.5 H0YB45 ENST00000355849.10 [O75525-1] ENST00000524199.5 A0A994J4I6 ENST00000517859.5 ENST00000521461.5 ENST00000524282.1 O75525 H0YAQ3 E5RG12 ENST00000704572.1 ENST00000520981.5 L8EAJ0 E5RHD3 |